NCT04808245 2025-09-22INTERCEPT-H3German Cancer Research CenterPhase 1 Active not recruiting15 enrolled
NCT04160494 2025-05-11D2C7-IT With Atezolizumab for Recurrent GliomasDuke UniversityPhase 1 Active not recruiting18 enrolled